Literature DB >> 2600939

A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis.

H B Berntzen1, E Munthe, M K Fagerhol.   

Abstract

L1 is a major granulocyte and monocyte protein. It is released during leukocyte activation, and the plasma level is thought to reflect the inflammatory activity. Fifteen patients with classical or definite rheumatoid arthritis were examined monthly during one year. The laboratory tests included L1, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), orosomucoid, haptoglobin, ceruloplasmin, alpha 1-antitrypsin, immunoglobulins and blood cell counts. The clinical tests included articular index, grip strength, morning stiffness and pain. The L1 protein was found to have highly significant correlations (p less than 0.0001) with orosomucoid (r = 0.86), CRP (r = 0.79), ESR (r = 0.78), haptoglobin (r = 0.75), alpha 1-antitrypsin (r = 0.63) and ceruloplasmin (r = 0.44). Significant correlation was also found between L1 and IgA. None of the laboratory variables showed significant correlation with pain, but when they were correlated with articular index, grip strength and morning stiffness, L1 was found to have the highest average correlation coefficient (p less than 0.0001).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2600939

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

1.  Effect of Hangeshashinto on calprotectin expression in human oral epithelial cells.

Authors:  Yuka Hiroshima; Mika Bando; Yuji Inagaki; Reiko Kido; Masatoshi Kataoka; Toshihiko Nagata; Jun-Ichi Kido
Journal:  Odontology       Date:  2015-02-04       Impact factor: 2.634

Review 2.  Functional and clinical aspects of the myelomonocyte protein calprotectin.

Authors:  B Johne; M K Fagerhol; T Lyberg; H Prydz; P Brandtzaeg; C F Naess-Andresen; I Dale
Journal:  Mol Pathol       Date:  1997-06

3.  Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight loss.

Authors:  Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Beatriz Ramírez; Fernando Rotellar; Victor Valentí; Camilo Silva; María J Gil; José Manuel Fernández-Real; Javier Salvador; Gema Frühbeck
Journal:  Mol Med       Date:  2011-07-05       Impact factor: 6.354

Review 4.  Calprotectin in rheumatic diseases.

Authors:  Francesca Ometto; Lara Friso; Davide Astorri; Costantino Botsios; Bernd Raffeiner; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-01

5.  Calprotectin expression inhibits bacterial binding to mucosal epithelial cells.

Authors:  K Nisapakultorn; K F Ross; M C Herzberg
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

6.  Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis.

Authors:  Hilde Berner Hammer; Sigrid Odegard; Magne K Fagerhol; Robert Landewé; Désirée van der Heijde; Till Uhlig; Petter Mowinckel; Tore K Kvien
Journal:  Ann Rheum Dis       Date:  2007-01-18       Impact factor: 19.103

7.  Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort.

Authors:  Miriam García-Arias; Dora Pascual-Salcedo; Susana Ramiro; Marie-Eve Ueberschlag; Thomas M Jermann; Carlos Cara; Emilio Martín-Mola; Alejandro Balsa
Journal:  Mol Diagn Ther       Date:  2013-02       Impact factor: 4.074

8.  Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro.

Authors:  G Hetland; G J Talgö; M K Fagerhol
Journal:  Mol Pathol       Date:  1998-06

9.  The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab.

Authors:  Hilde Berner Hammer; Magne K Fagerhol; Tale Norbye Wien; Tore K Kvien
Journal:  Arthritis Res Ther       Date:  2011-10-26       Impact factor: 5.156

10.  Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.

Authors:  Jana Hurnakova; Jakub Zavada; Petra Hanova; Hana Hulejova; Martin Klein; Herman Mann; Olga Sleglova; Marta Olejarova; Sarka Forejtova; Olga Ruzickova; Martin Komarc; Jiri Vencovsky; Karel Pavelka; Ladislav Senolt
Journal:  Arthritis Res Ther       Date:  2015-09-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.